Jill Weida
Nurse Practitioners (Family Nurse Practitioner)
- Medicare participating
At a glance
- Years since graduation
- 13
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 99
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Nurse Practitioner primary
TN license APN0000019309
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Tennessee Oncology PLLC (358 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 99
- Services billed
- 156
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 70 | 54 |
| Established patient office or other outpatient visit, 10-19 minutes | 50 | 41 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 28 payments worth $740 in total to this clinician.
| Merck Sharp & Dohme LLC | $228 |
|---|---|
| Eisai Inc. | $141 |
| GlaxoSmithKline, LLC. | $83.04 |
| Daiichi Sankyo Inc. | $80.92 |
| AstraZeneca Pharmaceuticals LP | $59.29 |
| AbbVie Inc. | $50.19 |
| Corcept Therapeutics | $49.53 |
| Verastem, Inc. | $31.06 |
| Food and Beverage | $740 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.